Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Naturally arising CD25(+)CD4(+) regulatory T cells actively maintain immunological self-tolerance. Deficiency in or dysfunction of these cells can be a cause of autoimmune disease. A reduction in their number or function can also elicit tumor immunity, whereas their antigen-specific population expansion can establish transplantation tolerance. They are therefore a good target for designing ways to induce or abrogate immunological tolerance to self and non-self antigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growing evidence has shown that Treg cells are recruited into the TME and behave as powerful immunosuppressors.61, 62”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [62]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Self-citationFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“In addition, they specifically express Foxp3 , which encodes a transcription factor, as a key control gene in their development and functio”
BackgroundPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationA CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Self-citationThe Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“The fact that many tumor-associated antigens recognized by autologous T cells in cancer patients are antigenically normal self constituents indicates that natural CD25 + CD4 + T reg cells engaged in the maintenance of self-tolerance may concomitantly impede immunosurveillance against autologous tumor cell”
BackgroundTivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Research works printed but not linked: 1
- Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. A crucial role of IL-2 in the homeostatic maintenance of CD25+CD4+ regulatory T cells: induction of autoimmune disease by neutralization of IL-2. J. Exp. Med. (in the press).
Cited by
Items 601–700 of 1,010
Prognostic Value of Tumor-Infiltrating FoxP3+ T Cells in Gastrointestinal Cancers: A Meta Analysis
Huang, Y. L., Liao, H., Zhang, Y., Yuan, R., Wang, F., Gao, Y., Wang, P., & Zhi, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094376 · Cited by 89
“Forkhead box protein P3 (FoxP3) is a transcription factor necessary and sufficient for induction of the immunosuppressive functions of Tregs, and it is now considered as the most specific marker for Tregs in tumors [2].”
BackgroundInfluentialCzaja, A. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12825 · Cited by 84
FOXP3 ensembles in T‐cell regulation
Li, B., Samanta, A., Song, X., Furuuchi, K., Iacono, K. T., Kennedy, S., Katsumata, M., Saouaf, S. J., & Greene, M. I. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00405.x · Cited by 78
Sainz-Perez, A., Lim, A., Lemercier, B., & Leclerc, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0277 · Cited by 75
“Numerous studies have shown the central role of Tregs in inducing and maintaining peripheral tolerance through various suppression mechanisms (4, 5).”
BackgroundTembhre, M. K., Parihar, A. S., Sharma, V., Sharma, A., Chattopadhyay, P., & Gupta, S. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13511 · Cited by 84
Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies
Boi, F., Pani, F., & Mariotti, S. (2017) · European Thyroid Journal · doi:10.1159/000468928 · Cited by 88
Pathological conditions re-shape physiological Tregs into pathological Tregs
Yang, W. Y., Shao, Y., Lopez‐Pastrana, J., Mai, J., Wang, H., & Yang, X. (2015) · Burns & Trauma · doi:10.1186/s41038-015-0001-0 · Cited by 90
“Since the first characterization of Tregs in 1995 [9,10], one of the major milestones in Tregs studies was the identification of FOXP3.”
BackgroundIncreased levels of (class switched) memory B cells in peripheral blood of current smokers
Brandsma, C., Hylkema, M. N., Geerlings, M., van Geffen, W. H., Postma, D. S., Timens, W., & Kerstjens, H. A. M. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-108 · Cited by 82
“Tregs express CD4, CD25 and forkhead transcription factor 3 (Foxp3) and are important in controlling immunological tolerance and preventing auto-immune reactions by inhibiting T-cell responses [10].”
BackgroundMechanisms of Disease: the evolving role of regulatory T cells in atherosclerosis
George, J. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1279 · Cited by 84
Nuclear Factor-κB in Immunity and Inflammation: The Treg and Th17 Connection
Ruan, Q., & Chen, Y. H. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0106-3_12 · Cited by 87
Forward, N. A., Furlong, S. J., Yang, Y., Lin, T., & Hoskin, D. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802509 · Cited by 82
“Although Treg cells constitute an important mechanism for regulating immune responses to both self- and foreign Ags (1, 2), optimal development of protective immune responses against invading microorganisms requires transient modulation of Treg cell activity.”
BackgroundRole of NKT cells in autoimmune liver disease
Santodomingo-Garzón, T., & Swain, M. G. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.06.003 · Cited by 86
Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease
Jia, L., Zhu, L., Wang, J. Z., Wang, X. J., Chen, J. Z., Song, L., Wu, Y., Sun, K., Yuan, Z., & Hui, R. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.01.027 · Cited by 82
Microbes and the Developing Gastrointestinal Tract
Neu, J., Douglas‐Escobar, M., & Lopez, M. (2007) · Nutrition in Clinical Practice · doi:10.1177/0115426507022002174 · Cited by 90
Notch1 modulates mesenchymal stem cells mediated regulatory T‐cell induction
Del Papa, B., Sportoletti, P., Cecchini, D., Rosati, E., Balucani, C., Baldoni, S., Fettucciari, K., Marconi, P., Martelli, M. F., Falzetti, F., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201242643 · Cited by 78
Trends and advances in tumor immunology and lung cancer immunotherapy
Aldarouish, M., & Wang, C. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0439-3 · Cited by 94
“Upon encountering antigens and adequate co-stimulation signals, naive CD4+ T cells are activated, polarized, and differentiated into distinct subsets including Th1, Th2 [20], Tregs [21], Th17, [22], Th9 [23], Th22 [24] and follicular helper T cells (TFH) [25].”
BackgroundOo, Y. H., Ackrill, S., Cole, R., Jenkins, L., Anderson, P., Jeffery, H. C., Jones, N., Jeffery, L. E., Lutz, P., Wawman, R. E., et al. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.08.001 · Cited by 79
“Tregs are a subset of CD4 T cells that maintain peripheral immune homeostasis by suppressing a range of effector immune responses to allow immune resolution and establish homeostatic balance between immune activation and tolerance.(8,9) In 1995, Sakaguchi and colleagues showed by adoptive transfer that subsets of CD4…”
BackgroundClinical tolerance in allogeneic hematopoietic stem cell transplantation
Roncarolo, M., Gregori, S., Lucarelli, B., Ciceri, F., & Bacchetta, R. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01010.x · Cited by 88
T cell‐mediated immunoregulation in the gastrointestinal tract
Saurer, L., & Mueller, C. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.01965.x · Cited by 89
“nTregs are characterized by their high expression of CD25 (CD4 CD25) and co-expression of the forkhead box P3 transcription factor (Foxp3) (24).”
BackgroundFelonato, M., Pina, A., de Araújo, E. F., Loures, F. V., Bazan, S. B., Feriotti, C., & Calich, V. L. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051071 · Cited by 86
“autoimmunity and excessive inflammatory responses against endogenous and exogenous aggressions [16,17].”
BackgroundBasso, A. S., Cheroutre, H., & Mucida, D. (2009) · Cell Research · doi:10.1038/cr.2009.26 · Cited by 104
“Indeed, self-reactive Foxp3 + regulatory T cells were also shown to be indispensable for preventing excessive and self-destructive immune responses [132].”
BackgroundJeong, D. C., Chung, N., Cho, B., Zou, Y., Ruan, M., Takahashi, Y., Muramatsu, H., Ohara, A., Kosaka, Y., Yang, W., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.089268 · Cited by 81
Clinical implication of recent advances in our understanding of IL-17 and reproductive immunology
Saito, S., Nakashima, A., Ito, M., & Shima, T. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.49 · Cited by 84
T lymphocytes and normal tissue responses to radiation
Schaue, D., & McBride, W. H. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00119 · Cited by 88
“…iTregs exert control of inflammatory responses at normal mucosal surfaces while nTregs appear more important for mediating self tolerance and tumor immune escape (Sakaguchi, 2004, 2005; Curotto de Lafaille and Lafaille, 2009; Haribhai et al., 2011; Rosenblum et al., 2011; Josefowicz et al., 2012).”
BackgroundThunberg, S., Akdis, M., Akdiş, C. A., Grönneberg, R., Malmström, V., Trollmo, C., van Hage, M., & Gafvelin, G. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02739.x · Cited by 87
Duan, X., Gao, S., Li, J., Wu, L., Zhang, Y., Li, W., Zhao, L., Chen, J., Yang, S., Sun, G., et al. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.12.005 · Cited by 86
Chen, X., & Oppenheim, J. J. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03460.x · Cited by 88
LaRosa, D. F., Gelman, A. E., Rahman, A. H., Zhang, J., Turka, L. A., & Walsh, P. T. (2007) · Immunology Letters · doi:10.1016/j.imlet.2006.12.007 · Cited by 79
The cross-talk between dendritic and regulatory T cells: good or evil?
Hubert, P., Jacobs, N., Caberg, J., Boniver, J., & Delvenne, P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1106694 · Cited by 95
Intra-tumoural regulatory T cells: A potential new target in cancer immunotherapy
Needham, D. J., Lee, J. X., & Beilharz, M. W. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.018 · Cited by 79
Finamore, A., Roselli, M., Donini, L. M., Brasili, E., Rami, R., Carnevali, P., Mistura, L., Pinto, A., Giusti, A. M., & Mengheri, E. (2019) · Nutrition · doi:10.1016/j.nut.2019.02.005 · Cited by 83
Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer
Wang, Y.-C., Chen, R., Wa, Y., Ding, S., Yang, Y., Liao, J., Tong, L., & Xiao, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.829451 · Cited by 89
“There is growing evidence for Treg cells’ active involvement in the negative regulation of various physiological and pathological immune responses (41).”
BackgroundThonhoff, J. R., Berry, J. D., Macklin, E. A., Beers, D. R., Mendoza, P. A., Zhao, W., Thome, A. D., Triolo, F., Moon, J. J., Paganoni, S., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200019 · Cited by 78
Zhang, Z., Ma, Y., Wang, H., Arp, J., Jiang, J., Huang, X., He, K. M., Garcia, B. M., Madrenas, J., & Zhong, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6920 · Cited by 78
“The suppressive function of CD4 Treg cells can be mediated by expression of IL-10, either surface CTLA-4 or membranebound TGF- (9, 33).”
BackgroundInfluentialMatarese, G., Procaccini, C., & Rosa, V. D. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108022 · Cited by 88
“The identification of mutations in the gene encoding Foxp3 as the cause of the fatal human autoimmune disorder “immune dysregulation, polyendocrinopathy, enteropathy, X-linked” and the analogous disease in a spontaneous mutant mouse, scurfy, was a breakthrough in the field and led to subsequent studies that argue for…”
BackgroundFoxp3 Represses Retroviral Transcription by Targeting Both NF-κB and CREB Pathways
Grant, C. W., Oh, U., Fugo, K., Takenouchi, N., Griffith, C., Yao, K., Newhook, T. E., Ratner, L., & Jacobson, S. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020033 · Cited by 88
COHAN, S. L., Hendin, B. A., Reder, A. T., Smoot, K. E., Avila, R. L., Mendoza, J. P., & Weinstock‐Guttman, B. (2021) · CNS Drugs · doi:10.1007/s40263-021-00822-z · Cited by 84
Zappasodi, R., Nicola, M. D., Carlo‐Stella, C., Mortarini, R., Molla, A., Vegetti, C., Albani, S., Anichini, A., & Gianni, A. M. (2008) · Haematologica · doi:10.3324/haematol.12521 · Cited by 83
van derVliet, H. J. J., Koon, H. B., Yue, S. C., Uzunparmak, B., Seery, V., Gavin, M. A., Rudensky, A. Y., Atkins, M. B., Balk, S. P., & Exley, M. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1662 · Cited by 76
Gonçalves, R. M., Salmazi, K. C., Santos, B. A. N., Bastos, M. S., Rocha, S. C., Boscardin, S. B., Silber, A. M., Kallas, E. G., Ferreira, M. U., & Scopel, K. K. G. (2010) · Infection and Immunity · doi:10.1128/iai.00578-10 · Cited by 77
“Treg cells are CD4 CD25 cells characterized by the intracellular expression of the forkhead box P3 (Foxp3) transcription factor that play a major role in the control of immune responses to self and environmental antigens, pathogens, and commensals (40).”
BackgroundVerma, N. D., Hall, B. M., Plain, K. M., Robinson, C. M., Boyd, R. A., Tran, G. T., Wang, C., Bishop, G. A., & Hodgkinson, S. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00190 · Cited by 87
“Natural CD4CD25 Treg (nTreg) prevent autoimmunity (7) and contribute to the induction of transplant tolerance (8).”
BackgroundImmunomodulatory Function of Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells
Zhao, Z.-G., Xu, W., Sun, L., You, Y., Li, F., Li, Q., & Zou, P. (2011) · Immunological Investigations · doi:10.3109/08820139.2011.607877 · Cited by 77
“However, several previous studies reported that regulatory DCs not only could expand the number of CD4+CD25+FOXP3+ Treg cells but also could produce anergic T cells (Sakaguchi, 2005; Kretschmer et al., 2005; Sato et al., 2003).”
BackgroundDings, R. P. M., Vang, K. B., Castermans, K., Popescu, F. E., Zhang, Y., Egbrink, M. G. A. O., Mescher, M. F., Farrar, M. A., Griffioen, A. W., & Mayo, K. H. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2443 · Cited by 78
Nagar, M., Vernitsky, H., Cohen, Y., Dominissini, D., Berkun, Y., Rechavi, G., Amariglio, N., & Goldstein, I. (2008) · International Immunology · doi:10.1093/intimm/dxn062 · Cited by 87
In Vitro Suppression of CD8+ T Cell Function by Friend Virus-Induced Regulatory T Cells
Robertson, S. J., Messer, R. J., Carmody, A., & Hasenkrug, K. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3342 · Cited by 86
“The IL-2R -chain (CD25) is expressed on a subset of CD4 T cells that exhibit suppressive activity, and this marker has commonly been used to identify natural Tregs (2).”
BackgroundImmunomodulatory Effect of Nigella sativa Oil on T Lymphocytes in Patients with Rheumatoid Arthritis
Kheirouri, S., Hadi, V., & Alizadeh, M. (2016) · Immunological Investigations · doi:10.3109/08820139.2016.1153649 · Cited by 78
“The suppressive effects of CD4CD25 Tregs on the adaptive immune system and in particular on CD4 T cells have been well documented (Sakaguchi, 2005; Thornton & Shevach, 1998).”
BackgroundThe imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients
Ma, L., Zhang, H., Hu, K., Lv, G., Fu, Y., Ayana, D. A., Zhao, P., & Jiang, Y. (2015) · BMC Immunology · doi:10.1186/s12865-015-0118-8 · Cited by 85
“Human Tregs are CD4CD25 and their development and function depends on the forkhead family transcription factor (Foxp3) expression [26–28].”
BackgroundYu, S., Maiti, P. K., Dyson, M. C., JAIN, R. K., & Braley‐Mullen, H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051438 · Cited by 76
Song, G., Wang, X., Jia, J., Yuan, Y., Fengling, W., Zhou, X., Yang, H., Ren, J., Gu, J., & Lyerly, H. K. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1424-8 · Cited by 78
miR26a Modulates Th17/Treg Balance in the EAE Model of Multiple Sclerosis by Targeting IL6
Zhang, R., Tian, A., Wang, J., Shen, X., Qi, G., & Tang, Y. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8335-5 · Cited by 82
Lehner, T. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02780.x · Cited by 82
PKC-θ function at the immunological synapse: prospects for therapeutic targeting
Zanin‐Zhorov, A., Dustin, M. L., & Blazar, B. R. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.04.007 · Cited by 87
Zheng, Q., Xu, Y., Liu, Y., Zhang, B., Li, X., Guo, F., & Zhao, Y. X. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0530-8 · Cited by 76
“It is well known that the majority of natural CD4CD25 Foxp3 Treg cells are produced in the thymus [13, 30, 31].”
BackgroundIdentification of heme oxygenase-1–specific regulatory CD8+ T cells in cancer patients
Andersen, M. H., Sørensen, R. B., Brimnes, M. K., Svane, I. M., Becker, J. C., & Straten, P. T. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38739 · Cited by 80
Re-establishing immunological self-tolerance in autoimmune disease
Sakaguchi, S., Powrie, F. M., & Ransohoff, R. M. (2012) · Nature Medicine · doi:10.1038/nm.2622 · Cited by 81
Self-citationGlisic-Milosavljevic, S., Waukau, J., Jailwala, P., Jana, S., KHOO, H., Albertz, H., Woodliff, J. E., Koppen, M., Alemzadeh, R., Hagopian, W., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000146 · Cited by 77
“Although a specific molecule for regulatory T cells is lacking, the transcription factor FoxP3 - forkhead box P3, has been identified as necessary for their development[12].”
BackgroundPereira, L. E., Villinger, F. J., Onlamoon, N., Bryan, P., Cardona, A. C., Pattanapanysat, K., Mori, K., Hagen, S. I., Picker, L. J., & Ansari, A. A. (2007) · Journal of Virology · doi:10.1128/jvi.00026-07 · Cited by 75
T cells, teeth and tissue destruction – what do T cells do in periodontal disease?
Campbell, L., Millhouse, E., Malcolm, J., & Culshaw, S. (2015) · Molecular Oral Microbiology · doi:10.1111/omi.12144 · Cited by 90
“Transforming growth factor-b (TGF-b) was detectable only at lower levels in disease tissues compared with healthy tissues (Dutzan et al., 2012).”
BackgroundInfluentialImmunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
Hossain, M., & Wall, K. (2016) · Vaccines · doi:10.3390/vaccines4030025 · Cited by 74
Tolerogenic dendritic cells and their potential applications: Therapeutic potential of DCs
Hu, J., & Wan, Y. (2011) · Immunology · doi:10.1111/j.1365-2567.2010.03396.x · Cited by 80
Lee, H.-H., Meyer, E. H., Goya, S., Pichavant, M., Kim, H. Y., Bu, X., Umetsu, S. E., Jones, J. C., Savage, P. B., Iwakura, Y., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001116 · Cited by 74
“In this case, immature DCs and other APCs expressing MFG-E8, brain-specific angiogenesis inhibitor 1, or TIM-4 engulf PtdSer-expressing apoptotic cells, produce IL-10 and/or TGF-b, and induce the development of peripheral T cell anergy/tolerance and regulatory T cells (44, 45).”
BackgroundChi, L., Wang, H., & Wang, W. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00158.x · Cited by 73
“Introduction In the peripheral immune system, CD4þCD25þ T regulatory cells (Tregs) have been shown to be one of important subsets of regulatory T cells involved in controlling inappropriate or excessive immune activation (Baecher-Allan et al., 2001; Sakaguchi, 2005).”
BackgroundQu, Y., Zhang, B., Liu, S., Zhang, A., Wu, T., & Zhao, Y. X. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.45 · Cited by 74
“9 These findings indicate that Foxp3 represents a key role in the development and function of CDpCD2p Treg cells”
BackgroundFOXP3+ regulatory T cells: From suppression of rejection to induction of renal allograft tolerance
Dummer, C. D., Carpio, V. N., Gonçalves, L. F. S., Manfro, R. C., & Veronese, F. V. (2011) · Transplant Immunology · doi:10.1016/j.trim.2011.08.009 · Cited by 80
Bebo, B. F., Dehghani, B., Foster, S., Kurniawan, A., Lopez, F. J., & Sherman, L. S. (2009) · Glia · doi:10.1002/glia.20805 · Cited by 71
“…not Increase the Frequency of Treg Cells in Mice with EAE Treg cells include different functional and phenotypic subpopulations and are characterized by a number of markers including CD4, CD25, CTLA-4, and FoxP3 (Fontenot et al., 2003; Sakaguchi, 2005; Sansom and Walker, 2006; Tang et al., 2004).”
BackgroundInfluentialCell- and peptide-based immunotherapeutic approaches for glioma
Yamanaka, R. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.03.003 · Cited by 78
Dynamic Behavior and Function of Foxp3+ Regulatory T Cells in Tumor Bearing Host
Qin, F. X.-F. (2009) · Cellular and Molecular Immunology · doi:10.1038/cmi.2009.2 · Cited by 79
Bonelli, M. M., Smolen, J. S., & Scheinecker, C. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.117135 · Cited by 74
The role of regulatory T cells in malignant glioma.
Sonabend, A. M., Rolle, C. E., & Lesniak, M. S. (2008) · PubMed · Cited by 82
Obesity and susceptibility to autoimmune diseases
Procaccini, C., Carbone, F., Galgani, M., Rocca, C. L., Rosa, V. D., Cassano, S., & Matarese, G. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.18 · Cited by 82
Galvão, R. P., & Zong, H. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-012-0006-3 · Cited by 80
“down an immune response once the threat to the host has been eliminated as well as in prevention of autoimmune disease [18].”
BackgroundAdeegbe, D. O., Bayer, A. L., Levy, R. B., & Malek, T. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7149 · Cited by 74
Initiating mechanisms of food allergy: Oral tolerance versus allergic sensitization
van Wijk, F., & Knippels, L. M. J. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.11.003 · Cited by 102
High frequency and proliferation of CD4+FOXP3+ Treg in HIV‐1‐infected patients with low CD4 counts
Bi, X., Suzuki, Y., Gatanaga, H., & Oka, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838667 · Cited by 73
Li, S., Folkvord, J. M., Rakasz, E. G., Abdelaal, H. M., Wagstaff, R. K., Kovács, K. J., Kim, H. O., Sawahata, R., MaWhinney, S., Masopust, D., et al. (2016) · Journal of Virology · doi:10.1128/jvi.01332-16 · Cited by 73
Horn, J., Manguiat, A., Berglund, L. J., Knerr, V., Tahami, F., Grimbacher, B., & Fulcher, D. A. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03913.x · Cited by 73
Identification and characterization of Foxp3+ γδ T cells in mouse and human
Kang, N., Tang, L., Li, X., Wu, D., Li, W., Chen, X., Cui, L., Ba, D., & He, W. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.06.005 · Cited by 73
“Recently, a study by Peng et al. [35] provided evidences for uman Tregs.”
InfluentialBayry, J., Sibéril, S., Triebel, F., Tough, D. F., & Kaveri, S. V. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.05.002 · Cited by 76
Little, P. J., Chait, A., & Bobik, A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.04.001 · Cited by 79
Attia, P., Powell, D. J., Maker, A. V., Kreitman, R. J., Pastan, I. H., & Rosenberg, S. A. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000187959.45803.0c · Cited by 74
“Treg cells constitutively express the a-chain of the interleukin (IL)-2 receptor (CD25), cytotoxic T-lymphocyte–associated antigen-4 (CTLA-4), glucocorticoid-induced tumor necrosis factor receptor (GITR), and transcription factor Forkhead box P3 (Foxp3).(2) Compared with CD25 CD4 T cells, CD25 Treg cells exhibit a hyp…”
BackgroundSaitoh, O., Abiru, N., Nakahara, M., & Nagayama, Y. (2007) · Endocrinology · doi:10.1210/en.2007-0300 · Cited by 73
Inada, K., Shima, T., Nakashima, A., Aoki, K., Ito, M., & Saito, S. (2013) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2012.12.001 · Cited by 80
Yi, S., Ji, M., Wu, J., Ma, X., Phillips, P. M., Hawthorne, W. J., & O’Connell, P. J. (2012) · Diabetes · doi:10.2337/db11-1306 · Cited by 73
“However, human natural Treg comprise only 5–10% of peripheral blood CD4 T cells (17), and large-scale ex vivo expansion would be required for any future clinical application (18).”
BackgroundAmbrosino, E., Spadaro, M., Iezzi, M., Curcio, C., Forni, G., Musiani, P., Wei, W., & Cavallo, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1432 · Cited by 80
Decreased FOXP3 expression in small airways of smokers with COPD
Isajevs, S., Taivāns, I., Strazda, G., Kopeika, U., Bukovskis, M., Gordjušina, V., & Kratovska, A. (2008) · European Respiratory Journal · doi:10.1183/09031936.00145307 · Cited by 73
Gammadelta T Cells: Innately Adaptive Immune Cells?
Ferreira, L. M. R. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.783831 · Cited by 85
“Nevertheless, treatment of mouse splenocytes with anti-γ δ TCR and TGF-β generated a population of Foxp3+ γ δ Tregs capable of inhibiting T cell activation by anti-CD3 [118].”
BackgroundInfluentialMeurens, F., Berri, M., Siggers, R. H., Willing, B. P., Salmon, H., Kessel, A. G. V., & Gerdts, V. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000677 · Cited by 79
“This observation is not surprising since inflammation in LF and GF groups is very low or null meaning that there is less a need of Tregs in the SI of these piglets.”
InfluentialMHC class II restricted neoantigen: A promising target in tumor immunotherapy
Sun, Z., Chen, F., Meng, F., Wei, J., & Liu, B. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.12.039 · Cited by 79
IL‐15 acts as a potent inducer of CD4+CD25hi cells expressing FOXP3
Imamichi, H., Sereti, I., & Lane, H. C. (2008) · European Journal of Immunology · doi:10.1002/eji.200737607 · Cited by 82
Vollmer, J. (2006) · International Reviews of Immunology · doi:10.1080/08830180600743107 · Cited by 79
Zhang, L., Yi, H., Xia, X., & Zhao, Y. X. (2006) · Autoimmunity · doi:10.1080/08916930600753903 · Cited by 87
Human regulatory T cells in allogeneic stem cell transplantation
Ukena, S. N., Velaga, S., Geffers, R., Grosse, J., Baron, U., Buchholz, S., Stadler, M., Bruder, D., Ganser, A., & Franzke, A. (2011) · Blood · doi:10.1182/blood-2011-05-352708 · Cited by 72
RETRACTED: Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth
Zorro Manrique, S., Duque Correa, M. A., Hoelzinger, D. B., Dominguez, A. L., Mirza, N., Lin, H.-H., Stein-Streilein, J., Gordon, S., & Lustgarten, J. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100730 · Cited by 67
“These cells are critical for the maintenance of peripheral T cell tolerance because their depletion leads to autoimmune disorders (Sakaguchi, 2005; Kim et al., 2007).”
BackgroundRetractedDysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities
Stroope, C., Nettersheim, F. S., Coon, B. G., Finney, A. C., Schwartz, M. A., Ley, K. F., Rom, O., & Yurdagul, A. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01015-w · Cited by 77
Samy, E. T., Wheeler, K. M., Roper, R. J., Teuscher, C., & Tung, K. S. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4366 · Cited by 72
“mus-derived, natural CD4 CD25 Foxp3 regulatory T cells (Treg)(5) (2).”
BackgroundMesenchymal stromal cells to promote solid organ transplantation tolerance
Casiraghi, F., Perico, N., & Remuzzi, G. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32835c5016 · Cited by 76
“The most extensively studied populations of Tregs are the so-called naturally occurring CD4þCD25þ Foxp3þ Treg that develop in the thymus [7,8] and the adaptive Tregs”
Role of regulatory T cells in coronavirus-induced acute encephalitis
Anghelina, D., Zhao, J., Trandem, K., & Perlman, S. (2009) · Virology · doi:10.1016/j.virol.2008.12.014 · Cited by 73
“…effector T cells in the brains of rJ.MY135Q-infected mice at all time points and were phenotypically and, by extrapolation from these studies of CLN-derived Tregs, functionally identical toTregs described in other settings (Nomura and Sakaguchi, 2005; Sakaguchi, 2005; Sakaguchi et al., 2006).”
BackgroundResultSempere-Ortells, J. M., Pérez-García, V., Marín-Alberca, G., Peris-Pertusa, A., Benito, J. M., de la Calle, F. M. M., Zubcoff, J., & Navarro-Blasco, F. J. (2009) · Autoimmunity · doi:10.3109/08916930903061491 · Cited by 72
Bouček, J., Mrkvan, T., Chovanec, M., Kuchař, M., Betka, J., Boucek, V., Hladíková, M., Betka, J., Eckschlager, T., & Řı́hová, B. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00650.x · Cited by 72
Regulatory T cells and Toll-like receptors: What is the missing link?
Dai, J., Liu, B., & Li, Z. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.01.027 · Cited by 77
“A key player inmaintaining peripheral Tcell tolerance is CD4CD25Foxp3 regulatory Tcells (Treg), whichpatrol thehostorgans against activationof self-reactive cells during steady state as well as in the settings of infections [5].”
Metadata
- Authors
- Sakaguchi, S.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Sakaguchi, Shimon
- ORCID
- Sakaguchi, Shimon
- Venue
- Nature Immunology
- Published
- 2005-03-22
- Volume
- 6
- Issue
- 4
- Pages
- 345-352
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2004708987
- Cited by
- 2,669
- References
- 109
- Citations by year
- 2026: 12 · 2025: 33 · 2024: 39 · 2023: 54 · 2022: 59 · 2021: 68 · 2020: 68 · 2019: 84 · 2018: 83 · 2017: 92 · 2016: 98 · 2015: 113 · 2014: 127 · 2013: 148 · 2012: 169
- FWCI
- 22.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Foxp3, regulatory T cells, CD4+CD25+ T cells, immune tolerance, self-tolerance, autoimmune disease, antitumor immunity, transplantation tolerance, antigen-specific T cell expansion, immunomodulation
- MeSH terms
- Animals, Antigens, Differentiation, Autoimmune Diseases, DNA-Binding Proteins, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Thymus Gland, Transplantation Immunology, Receptors, Interleukin-2, Antigens, CD, CD4 Antigens, Self Tolerance, Forkhead Transcription Factors, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.